• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problems Abscess (1690); Obstruction/Occlusion (2422)
Event Date 09/07/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following literature was reviewed.¿consideration about two cases which were performed surgical treatment for infection of viabahn stent graft after evt.¿ jun okatome, et al.Official journal of the japanese society for vascular surgery, 2021: 30(suppl.) p.O48-4.Case 1: the patient was a (b)(6) year old male, on maintenance dialysis for type 2 diabetes.He underwent evt for left lower limb pain (the right groin was punctured and a cross over technique was performed).The following day it was reported that the untreated right lower limb felt cold.An abi exam was performed, but results for the right side were inconclusive.Upon further examination, the right sfa, which had been found to be patent the day before, was occluded.A gore® viabahn® endoprosthesis was implanted in the right sfa.However, the next day, a re-occlusion was confirmed.An additional viabahn stent graft was implanted to treat the occlusion.After the treatment, the symptoms in the lower limbs improved, but fever and inflammatory reaction increased from the day after the final evt.Various tests indicated that an abscess formation was suspected around the stent grafts in the right superficial femoral artery.Although an antibiotic treatment and a puncture drainage were performed, there was no improvement.The right sfa / stent graft resection was performed surgically.Wound treatment continued post operation, and it was later confirmed that the wound was healed.The patient was transferred to the rehabilitation hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kaitlin barnash
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12549906
MDR Text Key274024787
Report Number2017233-2021-02411
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 09/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/07/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age79 YR
-
-